Enhanced in vivo anti-tumor efficacy of whole tumor lysate in combination with whole tumor cell-specific polyclonal antibody
Background and purpose: Despite the widespread utilization of cancer vaccines with specified antigens, the use of whole tumor cell lysates in tumor immunotherapy would be a very promising approach that can overcome several significant obstacles in vaccine production. Whole tumor cells provide a broa...
Main Authors: | Ilnaz Rahimmanesh, Yasaman Esmaili, Elham Ghafouri, Seyed Hossein Hejazi, Hossein Khanahmad |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2023;volume=18;issue=2;spage=138;epage=148;aulast=Rahimmanesh |
Similar Items
-
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
by: Lu Diao, et al.
Published: (2023-08-01) -
In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters
by: Inken Salewski, et al.
Published: (2020-10-01) -
Activation of Cellular Players in Adaptive Immunity via Exogenous Delivery of Tumor Cell Lysates
by: Jihyun Seong, et al.
Published: (2022-06-01) -
Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma
by: Michael R. Olin, et al.
Published: (2019-01-01) -
Dendritic cells pulsed with generated tumor cell lysate from Phyllanthus amarus Schum. & Thonn. induces anti-tumor immune response
by: Shimaa Ibrahim Abdelmenym Mohamed, et al.
Published: (2018-08-01)